Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Clin Psychol Sci. 2016 Aug 8;4(6):1125–1134. doi: 10.1177/2167702616645777

Table 1.

Comparison of characteristics as a function of having recurrent depressive symptoms (DepS) in the 4246 Whitehall II participants

Recurrence of DepS over the 5-year of follow-up
Characteristics of
participants at baseline
Whole Sample (n=4246) Men (n=3178) Women (n=1068)
No
n=3981
Yes
n=265
No
n=3012
Yes
n=166
No
n=969
Yes
n=99

% or
m±SD
% or
m±SD
P % or
m±SD
% or
m±SD
P % or
m±SD
% or
m±SD
P
Sociodemographic factors
  Sex Men 75.7 62.6 <.001 / / / /
Women 24.3 37.4 / / / /
  Age (y) 61.0±5.9 60.1±5.9 0.02 61.0±5.9 59.7±5.7 0.01 61.0±5.9 60.8±6.2 0.75
  Ethnicity White 95.6 86.8 <.001 96.5 88.0 <.001 93.1 84.9 <.001
South Asian 3.1 12.6 2.9 11.5 3.8 14.1
Black 1.2 0.8 0.6 0.6 3.1 1.0
  SES Low 7.4 15.1 <.001 2.3 6.6 <.001 23.2 29.3 0.02
  Inverse ok Medium 40.9 50.2 38.2 46.4 49.4 56.6
High 51.7 34.7 59.5 47.0 27.4 14.1
  Marital
  Status
Married 78.7 64.9 <.001 84.6 74.7 0.001 60.4 48.5 0.02
Living alone 21.3 35.1 15.4 25.3 39.6 51.5
Health behavior factors
  Smoking
  habits
Never 50.2 50.9 0.01 48.2 46.4 0.02 56.4 58.6 0.51
Ex 43.1 37.7 45.7 42.2 35.1 30.3
Current 6.7 11.3 6.1 11.5 8.6 11.1
  Alcohol
  Intake
No 13.4 21.9 0.001 9.8 13.3 0.20 24.6 36.4 0.03
Moderate 63.6 56.2 65.8 59.6 56.7 50.5
Heavy drinker 23.0 21.9 24.3 27.1 18.8 13.1
  Physical
  activity
Inactive 22.3 34.3 <.001 20.8 31.9 <.001 26.9 38.4 0.02
Mod. Active 16.0 23.4 14.6 24.1 20.3 22.2
Active 61.7 42.3 64.6 44.0 52.7 39.4
  Total energy intake (kcal/d) 2191±636 2253±772 0.21 2255±636 2337±787 0.19 1994±596 2112±729 0.12
Health status factors
  Type 2 diabetes 8.4 10.6 0.23 8.2 11.5 0.14 9.3 9.1 0.95
  Central obesity 27.4 35.5 0.005 22.1 28.3 0.06 44.0 47.5 0.50
  Cardiovascular Diseases 8.0 12.5 0.01 8.7 11.5 0.23 5.8 14.1 0.001
  Hypertension 35.9 37.4 0.63 35.8 38.0 0.57 36.3 36.4 0.99
  HDL cholesterol (mmol/L) 1.6±0.4 1.6±0.4 0.37 1.5±0.4 1.5±0.4 0.31 1.9±0.5 1.7±0.5 0.01
  Use of lipid-lowering drugs 11.0 13.2 0.26 11.6 14.5 0.26 9.2 11.1 0.53
  Cognitive impairment 11.5 19.3 <.001 11.1 18.7 0.003 12.7 20.2 0.04
Exposure
Dietary Inflammatory Index
  (points)
−0.03±1.3 0.12±1.5 0.12 −0.03±1.3 −0.02±1.5 0.92 −0.04±1.4 0.33±1.5 0.01